Table 2. Adverse effects of osteoporosis drugs.
| Drug | Common adverse events | Notable rare adverse events |
|---|---|---|
| Oral bisphosphonate | Hypocalcaemia Upper gastrointestinal effects (gastro-oesophageal reflux, erosive oesophagitis) |
Osteonecrosis of the jaw* Atypical femoral fractures † |
| Intravenous bisphosphonates | Hypocalcaemia Flu-like illness following infusion |
Osteonecrosis of the jaw* Atypical femoral fractures † |
| Denosumab | Hypocalcaemia Injection-site reactions Atraumatic vertebral fractures following discontinuatio |
Osteonecrosis of the jaw* Atypical femoral fractures † |
| Raloxifene | Hot flushes Venous thromboembolism |
Stroke |
| Teriparatide | Hypercalcaemia Injection-site reactions |
Theoretical risk of osteosarcoma |
| Romosozumab | Injection-site reactions | Possible increased risk of major adverse cardiovascular events (myocardial infarction, stroke) Osteonecrosis of the jaw* (few case reports) Atypical femoral fractures † (few case reports) |
* Risk factors include dental extractions, implants, poorly fitting dentures, pre-existing dental disease, glucocorticoid use and smoking.
† Risk factors include rheumatoid arthritis, increased femoral bowing, thicker lateral cortices at the femoral shaft and Asian ethnicity.